Neuroendocrine Cancer: Medical Treatments
Commons · Question 127170 · Tabled 14 Apr 2026 · Department of Health and Social Care · Official record
Answered 20 Apr 2026
Question
Asked by Manuela Perteghella
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of patient access to specialist treatments for neuroendocrine cancer, including peptide receptor radionuclide therapy.
Answer
Answered by Sharon Hodgson, 20 Apr 2026
Improving the early diagnosis of rare cancers, including neuroendocrine cancers, is a priority for the Government. In February, the Government published the first ever National Cancer Plan with a dedicated chapter on rare cancers.The Government is committ...